Latest filing published 17 Aug 2022 for Insight Molecular Diagnostics Inc., €9,808.
Filing timeline
BuySaleInsider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- -80.1%Entry US$18.40 · Close at T+365 US$3.66
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Jennifer L. Carter: trading record in brief
This profile gathers the share dealings of Jennifer L. Carter in Insight Molecular Diagnostics Inc. The record holds 3 filings, for trades running from 24 June 2022 to 16 August 2022.
On the market, this insider has only ever bought: 1 purchase, €9,808 in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant and 1 option exercise.
Most recently, on 17 August 2022, the filings show an open-market purchase worth €9,808 in Insight Molecular Diagnostics Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jennifer L. Carter
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 10,500 shares@ US$0.95100.0% of flowCommon Stock, no par valueSEC:0001493152-22-023376:1Canonical exit: 14 Nov 2022 (T+90)
- 10,000 shares0Common Stock, no par valueSEC:0001493152-22-023376:0
- 10,000 shares0Common Stock, no par valueSEC:0001493152-22-019821:0
3 of 3 declarations
